Clinical trial Recruiting at 1 site Observational Ages 18 and up

Subcostal echo method for measuring cardiac output

Official title: Discontinuous Echocardiographic Subcostal Cardiac Output Measurement by the Right Ventricular Outflow Tract in Critical Care

Run by University Hospital, Rouen · NCT07177391 · Data updated 2026-11-12

This project tries a subcostal (under-the-rib) echocardiogram method to measure cardiac output in adult ICU patients who need echocardiography.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversity Hospital, Rouen
Academic / other
Locations1 site (Rouen)
StatusRecruiting
StartedNovember 25, 2024
Main results expectedSeptember 9, 2025
Study endsOctober 30, 2025
Registry record updatedSeptember 17, 2025
Trial IDNCT07177391 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult patients (≥18 years) admitted to the Rouen University Hospital ICU who require transthoracic echocardiography for diagnosis or therapeutic monitoring are eligible.

Probably not a fit

Patients who are pregnant, actively dying, legally incapacitated without consent, not affiliated with social security, or those who refuse participation are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project uses the subcostal transthoracic echocardiography route to obtain right ventricular outflow tract measurements and time-velocity integrals to calculate cardiac output without adding invasive devices. Measurements are taken during routine echocardiographic exams in adult patients admitted to the Rouen University Hospital intensive care unit, adding only seconds or minutes to standard practice. The method applies the same mathematical principles used for left ventricular outflow tract cardiac output calculation but via the subcostal view and right ventricular outflow tract. Data will describe feasibility, image quality, and the practicality of discontinuous subcostal cardiac output measurement in critically ill, less mobilizable patients.

Why it matters

Potential benefit: If successful, this method could provide a quicker, less invasive, and lower-cost way to monitor cardiac output at the bedside in critically ill patients.

How similar studies have gone: Echocardiography-based cardiac output measurement via the left ventricular outflow tract is established, but using a subcostal right ventricular outflow tract approach for cardiac output has not been described in the literature and is therefore novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient (Age ≥ 18 years)
* Patient admitted to the intensive care unit at Rouen University Hospital.
* Transthoracic echocardiography (TTE) is required upon admission or during the patient's stay for diagnostic assessment and/or therapeutic monitoring.

Exclusion Criteria:

* Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection/guardianship or curatorship
* Patient not affiliated with the social security system
* Refusal by the patient or trusted person if the patient is incapable of expressing consent
* Pregnant woman
* Dying patient

Where it's running

  • University Rouen Hospital
    Rouen, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.